Variability in Emergency Medicine (EM) Provider Decisions on Hospital Admission and Antibiotic (ABX) Treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
نویسندگان
چکیده
695. Physician Perceptions and Attitudes Towards an Antimicrobial Stewardship Program and Computerized Decision-making Systems: A Focus Group Study Alvin Qijia Chua, BSc (Pharm) (Hons); Sing Teang Kong, PhD; Lai Wei Lee, BSc (Pharm) (Hons); Daphne Yah Chieh Yii, BPharm; Sarah Si Lin Tang, BSc (Pharm) (Hons); Winnie Lee, BPharm (Hons), MSc (Epi); Andrea L. Kwa, PharmD and Desiree Lie, MD, MSED; Pharmacy, Singapore General Hospital, Singapore, Singapore, Duke-National University of Singapore Medical School, Singapore, Singapore, Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore
منابع مشابه
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
OBJECTIVE The FDA recently issued guidance for the types of infections that should be included in trials to support an indication for antibacterial treatment. The latest FDA guidance recommends assessing response to drug therapy at 48 to 72 hours as the primary endpoint in clinical trials. This study evaluated clinical and economic outcomes among acute bacterial skin and skin structure infectio...
متن کاملTreatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting
Acute bacterial skin and skin structure infections (ABSSSIs), which include cellulitis, abscesses, and wound infections, are among the most commonly encountered conditions in emergency departments (EDs) internationally. Primarily, as a result of the recent epidemic of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) in North America, ED attendances and hospital admissi...
متن کاملEfficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials
BACKGROUND The objective of this analysis was to evaluate the efficacy and safety of oritavancin compared with vancomycin for patients with acute bacterial skin and skin structure infections (ABSSSIs) who received treatment in the outpatient setting in the Phase 3 SOLO clinical trials. METHODS SOLO I and SOLO II were 2 identically designed comparative, multicenter, double-blind, randomized st...
متن کامل1331The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
1331. The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Ralph Corey, MD; Matthew Wikler, MD; Greg Moeck,; Hai Jiang,; Samantha Good,; Solo I and II Investigators; Medicine Infectious Diseases, Duke University Medical Center, Durham, NC; The Medicines Company, Parsippany, NJ
متن کامل266Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
266. Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies Sailaja Puttagunta, MD; Helen Boucher, MD, FIDSA; George Talbot, MD; Mark Wilcox, MD; Michael Dunne, MD; Durata Therapeutics, Branford, CT; Tufts New England Medical Center, Boston, MA; Talbot Advisors LLC, Anna Maria, FL; Microbiology, Leeds T...
متن کامل